Literature DB >> 23784703

D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review.

Marie-Claire F Kleinegris1, Hugo ten Cate, Arina J ten Cate-Hoek.   

Abstract

Peripheral artery disease (PAD) is associated with an increased risk for cardiovascular events. D-dimers are a marker for hypercoagulability and are linked with thrombotic events in patients with venous as well as arterial thrombosis. The predictive value of plasma D-dimer levels in relation to cardiovascular events in patients with PAD is not unambiguously established. It was our objective to gather evidence evaluating the value of D-dimer as a predictor of arterial thrombotic events patients with PAD. The Pubmed, Embase, and Cochrane databases were searched (January 1980-November 2012), and 65 abstracts were found. The strategy was supplemented with manual review of reference lists. Case-control, cohort or prospective cohort studies that measured fibrin D-dimer in patients with PAD, were included. Studies were excluded if there was no follow-up for arterial thrombotic events or when no specific information on D-dimer was available. The search yielded 10 studies for our analysis, comprising 2,420 patients with PAD, with a total of 1,036 cardiovascular events in 10,599 patient-years. Two studies with a follow-up of one year showed that fibrin D-dimer predicts both deterioration of PAD and subsequent thrombotic events. Five out of six studies with a median follow-up of 2-4 years revealed that an increased D-dimer is predictive of various arterial thrombotic events including mortality. Two studies with a longer follow-up (over 6 years) did not show an independent association between increased D-dimer levels, arterial thrombotic events and CVD mortality. In conclusion, an increased D-dimer appeared to be independently associated with a two times increased risk of near-term cardiovascular events (relative risk 2.30, 95% confidence interval 1.43-3.68). However formal meta-analysis was only feasible for four out of 10 included studies. Due to the extended heterogeneity of the included studies cautious interpretation of these data is warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784703     DOI: 10.1160/TH13-01-0032

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Anjum Hajat; Matthew Allison; Ana V Diez-Roux; Nancy Swords Jenny; Neal W Jorgensen; Adam A Szpiro; Sverre Vedal; Joel D Kaufman
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

2.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

3.  Successful resolution of a left ventricular thrombus with apixaban treatment following acute myocardial infarction.

Authors:  Yoshinori Mano; Kimi Koide; Hiroaki Sukegawa; Masaki Kodaira; Takahiro Ohki
Journal:  Heart Vessels       Date:  2014-08-01       Impact factor: 2.037

4.  Air quality improvement during 2010 Asian games on blood coagulability in COPD patients.

Authors:  Zili Zhang; Jian Wang; Meihua Guo; Mingmei Xiong; Qipeng Zhou; Defu Li; Jiaze Shu; Wenju Lu; Dejun Sun
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-09       Impact factor: 4.223

5.  Evidence of Disseminated Intravascular Coagulation in a Porcine Model Following Radiation Exposure.

Authors:  G S Krigsfeld; J B Shah; J K Sanzari; L Lin; A R Kennedy
Journal:  Life Sci Space Res (Amst)       Date:  2014-10-01

6.  Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case-Control Study.

Authors:  Marie-Claire F Kleinegris; Joke Konings; Jan W Daemen; Yvonne Henskens; Bas de Laat; Henri M H Spronk; Arina J Ten Cate-Hoek; Hugo Ten Cate
Journal:  Front Cardiovasc Med       Date:  2017-04-20

Review 7.  Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis.

Authors:  Huaibin Wan; Shuang Wu; Yanmin Yang; Jun Zhu; Aidong Zhang; Yan Liang
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

8.  The coagulation system in atherothrombosis: Implications for new therapeutic strategies.

Authors:  Renske H Olie; Paola E J van der Meijden; Hugo Ten Cate
Journal:  Res Pract Thromb Haemost       Date:  2018-02-19

9.  D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.

Authors:  Laura M Raffield; Neil A Zakai; Qing Duan; Cecelia Laurie; Joshua D Smith; Marguerite R Irvin; Margaret F Doyle; Rakhi P Naik; Ci Song; Ani W Manichaikul; Yongmei Liu; Peter Durda; Jerome I Rotter; Nancy S Jenny; Stephen S Rich; James G Wilson; Andrew D Johnson; Adolfo Correa; Yun Li; Deborah A Nickerson; Kenneth Rice; Ethan M Lange; Mary Cushman; Leslie A Lange; Alex P Reiner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09-14       Impact factor: 8.311

10.  Elevated level of D-dimer increases the risk of stroke.

Authors:  Jing Zhang; Yanlin Song; Baoyin Shan; Min He; Qingqing Ren; Yunhui Zeng; Zhiyong Liu; Hao Liu; Jianguo Xu
Journal:  Oncotarget       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.